» Articles » PMID: 8140059

Primary Culture of Rat Gastric Epithelial Cells As an in Vitro Model to Evaluate Antiulcer Agents

Overview
Journal Pharm Res
Specialties Pharmacology
Pharmacy
Date 1994 Jan 1
PMID 8140059
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

Primary rat gastric cell cultures were investigated as an in vitro model for evaluating antiulcer agents. Following exposure to concentrations of up to 5 mg/mL of an antiulcer agent sucralfate, an aluminum hydroxide complex of sucrose octasulfate, cultured cells were treated with either pH 3.5 medium or 3.5 mM indomethacin. Cytoprotection was evaluated by colony forming efficiency, neutral red uptake, and 3-(4,5-dimethyl-2-thiazoyl)-2,5-diphenyl-2H-tetrazolium bromide (MTT) hydrolysis. By each measure, and depending on damaging agent, 2 and 5 mg/mL sucralfate provided partial (50% of untreated control) to near-complete (90% of untreated control) cytoprotection, respectively. Aluminum hydroxide also provided partial (55% of untreated control) to near-complete (more than 90% of untreated control) cytoprotection at 2 and 5 mg/mL, respectively, for the pH 3.5 medium-induced damage. Over a concentration range of 0.05 to 5 mg/mL, the potassium salt of sucrose octasulfate, KSOS, stimulated cell growth up to 40-60% over untreated controls but had little or no cytoprotective action in the presence of either 3.5 mM indomethacin or pH 3.5 medium. Overall results suggested that sucralfate may have at least two roles in influencing gastric epithelial cell function, cytoprotection and stimulation of cell growth in vitro. These observations serve as a basis for further study of in vitro models in evaluating the cytoprotective activity of antiulcer agents and their respective mechanisms of action.

Citing Articles

Structural basis for activation of fibroblast growth factor signaling by sucrose octasulfate.

Yeh B, Eliseenkova A, Plotnikov A, Green D, Pinnell J, Polat T Mol Cell Biol. 2002; 22(20):7184-92.

PMID: 12242295 PMC: 139814. DOI: 10.1128/MCB.22.20.7184-7192.2002.


Characterization of JOK-1, a human gastric epithelial cell line.

Okayama N, Fowler M, Jennings S, Specian R, Alexander B, Jackson T In Vitro Cell Dev Biol Anim. 2000; 36(4):228-34.

PMID: 10852347 DOI: 10.1290/1071-2690(2000)036<0228:cojahg>2.0.co;2.

References
1.
Nagashima R . Development and characteristics of sucralfate. J Clin Gastroenterol. 1981; 3(Suppl 2):103-10. View

2.
Romano M, Razandi M, Ivey K . Effect of sucralfate and its components on taurocholate-induced damage to rat gastric mucosal cells in tissue culture. Dig Dis Sci. 1990; 35(4):467-76. DOI: 10.1007/BF01536921. View

3.
Martin F, Farley A, Gagnon M, Bensemana D . Comparison of the healing capacities of sucralfate and cimetidine in the short-term treatment of duodenal ulcer: a double-blind randomized trial. Gastroenterology. 1982; 82(3):401-5. View

4.
COHEN M, Bowdler R, Gervais P, Morris G, Wang H . Sucralfate protection of human gastric mucosa against acute ethanol injury. Gastroenterology. 1989; 96(2 Pt 1):292-8. DOI: 10.1016/0016-5085(89)91550-3. View

5.
Okabe S, Takeuchi K, Kunimi H, Kanno M, Kawashima M . Effects of an antiulcer drug, sucralfate (a basic aluminum salt of sulfated disaccharide), on experimental gastric lesions and gastric secretion in rats. Dig Dis Sci. 1983; 28(11):1034-42. DOI: 10.1007/BF01311733. View